Pegfilgrastim biosimilar (Coherus BioSciences)

培非格司亭生物类似药 (Coherus BioSciences)

Report date: 2024/02/28 16:03:39

Base Information

Drug NamePegfilgrastim biosimilar (Coherus BioSciences)
Drug Alias NamePegfilgrastim-cbqv聚乙二醇非格司亭 (Coherus BioSciences)聚乙二醇非格司亭生物类似药 (Coherus BioSciences)UDENYCA ONBODYUDENYCA® OBI +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsAcute Radiation SyndromeFebrile NeutropeniaNeutropenia
Global Approved IndicationsFebrile NeutropeniaNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2018/09/21
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCoherus Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCoherus Biosciences IncIntas Pharmaceuticals LtdAccord Biopharma Inc
Inactive CompaniesEra Consulting Gmbh
Active IndicationsAcute Radiation SyndromeFebrile Neutropenia
Inactive IndicationsNeutropenia

Other Information

ATC CodeL03AA13
Related LinksWikipediaDrugBankKEGG